UPC_APP_47154/2024

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Procedural & sub-applicationsDocument Access (RoP262)Munich CDGenericWritten Phase

2024-10-22Procedural onlyproceduralApplication RoP262.1 (b)
The Munich Central Division Section ruled on a third-party access application (R. 262.1(b) RoP) by Dehns (a large UPC representative firm) seeking access to all written pleadings and evidence in the Amgen-Regeneron revocation and counterclaim proceedings concerning EP 3 666 797 (decided on 16 July 2024). The court distinguished between procedural documents falling and not falling within the categories of 'written pleadings' and 'evidence', granting access to the qualifying documents.